ロングリードシーケンス市場 – 2029年までの世界予測

Report Overview

The long-read sequencing market is expected to reach USD 3,129 million in 2029 from USD 758 million in 2024, at a CAGR of 32.8% during the forecast period.

ロングリードシーケンス市場は、予測期間中に32.8%のCAGRで、2024年の7億5,800万米ドルから2029年には31億2,900万米ドルに達すると予想されます。

Growth in the long-read sequencing market is mainly driven by factors like increasing collaborations between academic institutions and industry players, decreased cost of sequencing, and continuous technological advancements in long-read sequencing. Moreover, the application of LRS like de novo genome assembly, structural variant detection, transcriptomics, and epigenetics is supporting the market growth. However, the initial cost concern to set up the equipment is impacting the growth of the long-read sequencing market.

“The consumables segment accounted for the largest share by offerings segment in the long-read sequencing market in 2023”

The long-read sequencing market is segmented into consumables, instruments, and services in 2023. The consumables is the segment with the largest share in offerings. The large share of consumables is due to their role in sample preparation, sequencing, and data analysis part of long-read sequencing. As the demand for sequencing increases, it supports the demand for the consumables segment, driving its growth in the market. Still, the instrument segment held the second-largest market share.

“The academic & research institutes segment accounted for the largest share by end-user segment in the long-read sequencing market in 2023”

The long-read sequencing market is segmented into academic & research institutes, pharmaceutical & biotechnologies companies, hospitals, clinics & diagnostics laboratories, and other end users. The academic & research institutes are the segment with the largest share in the end-user segment in 2023. The large share of academic & research institutes is due to the increased demand for whole genome sequencing products, and increased genomics research. However, the pharmaceutical & biotechnological companies accounted for the second largest share in the segment.

“The Asia Pacific region is growing at the highest CAGR in the long-read sequencing market from 2024 to 2029.”

The Asia Pacific is estimated to be the fastest-growing segment of the market owing to the large scale of population genomics projects, and the demand for precision medicines is supporting the growth. Further, the rising prevalence of chronic diseases is attributed to the aging population of countries such as Japan, and China. These is supporting the adoption of sequencing technologies in healthcare prognosis and treatment driving the market growth.

The primary interviews conducted for this report can be categorized as follows:

• By Respondent: Supply Side- 70% and Demand Side 30%
• By Designation: Managers – 45% CXOs and Director-level – 30%, and Executives – 25%,
• By Region: North America -40%, Europe -25%, Asia-Pacific -25%, Latin America -5%, and Middle East -5%.

List of Companies Profiled in the Report:

• Oxford Nanopore Technologies plc. (UK)
• PacBio (US)
• Illumina, Inc. (US)
• Agilent Technologies, Inc. (US)
• Thermo Fisher Scientific Inc. (US)
• 10X Genomics, Inc. (US)
• QIAGEN (Germany)
• BGI Group (China)
• Takara Bio Inc. (Japan)
• Azenta US, Inc. (US)
• Revvity, Inc. (US)
• Danaher Corporation (US)
• Novogene Co., Ltd. (China)
• New England Biolabs (US)
• BaseClear BV (Netherlands)
• Element Biosciences (US)
• Grandomics (China)
• CD Genomics (US)
• Sage Sciences, Inc. (US)
• EdenRoc Sciences (US)

Research Coverage:

This research report categorizes the long-read sequencing market by offerings (instruments, consumables, and services), technology (single-molecule real-time sequencing, nanopore sequencing,  and synthetic long-read sequencing), workflow (sample preparation, sequencing, and data analysis), application (whole genome sequencing, metagenomics, epigenetics, targeted sequencing, whole exome sequencing, and other applications), usage (research and clinical), end user (academic & research institutes, pharmaceutical & biotechnology companies, hospitals, clinics & diagnostic Labs, and other end users), and by region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, challenges, opportunities, and restraints influencing the growth of the long-read sequencing market. A detailed analysis of the key industry players has been done to provide insights into their business overview, product & service portfolio, key strategies such as collaborations, expansions, agreements, and recent developments associated with the long-read sequencing market. Competitive analysis of top players and upcoming startups in the long-read sequencing market ecosystem is covered in this report.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall long-read sequencing market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

Analysis of key drivers (Technological advancements in genome sequencing, Increased prevalence of complex and rare genetic disorders, and growing demand for high-quality throughput screening), restraints (High investments to develop long read sequencing technologies, Technical Limitations of existing technology), opportunities (Rising demand for long-read sequencing in clinical genomics, and expanding applications of long-read sequencing), and challenges (challenges associated with data preservation, analysis, and validation) influencing the growth of the market.

• Product Development/Innovation: Detailed insights on newly launched services of the long-read sequencing market
• Market Development: Comprehensive information about lucrative markets – the report analyses the market across varied regions.
• Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the long-read sequencing market
• Competitive Assessment: Oxford Nanopore Technologies plc. (UK), PacBio (US), Illumina, Inc. (US), Agilent Technologies, Inc. (US), Thermo Fisher Scientific Inc. (US), 10X Genomics, Inc. (US), QIAGEN (Germany), BGI Group (China), Takara Bio Inc. (Japan), Azenta US, Inc. (US), Revvity, Inc. (US), Danaher Corporation (US), Novogene Co., Ltd. (China), New England Biolabs (US), BaseClear BV (Netherlands), Element Biosciences (US), Grandomics (China), CD Genomics (US), Sage Sciences, Inc. (US), and EdenRoc Sciences (US) among others in the market.

Table of Contents

1               INTRODUCTION        31

1.1            STUDY OBJECTIVES 31

1.2            MARKET DEFINITION                31

1.2.1        INCLUSIONS & EXCLUSIONS   32

1.3            MARKET SCOPE      33

1.3.1        MARKETS COVERED                 33

1.3.2        YEARS CONSIDERED                34

1.3.3        CURRENCY CONSIDERED        34

1.4            STAKEHOLDERS      34

2               RESEARCH METHODOLOGY    35

2.1            RESEARCH DATA     35

2.1.1        SECONDARY DATA   35

2.1.2        PRIMARY DATA         36

2.2            MARKET ESTIMATION METHODOLOGY   38

2.2.1        MARKET SIZE ESTIMATION      38

2.2.2        TOP-DOWN APPROACH            41

2.3            MARKET GROWTH RATE PROJECTIONS  42

2.4            DATA TRIANGULATION              44

2.5            RESEARCH ASSUMPTIONS     44

2.6            RESEARCH LIMITATIONS         45

2.7            RISK ANALYSIS        45

3               EXECUTIVE SUMMARY             46

4               PREMIUM INSIGHTS                 51

4.1            LONG-READ SEQUENCING MARKET OVERVIEW      51

4.2            ASIA PACIFIC: LONG-READ SEQUENCING MARKET, BY OFFERING          52

4.3            LONG-READ SEQUENCING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES     53

4.4            LONG-READ SEQUENCING MARKET SHARE, BY END USER, 2023         53

5               MARKET OVERVIEW 54

5.1            INTRODUCTION        54

5.2            MARKET DYNAMICS                 54

5.2.1        DRIVERS  55

5.2.1.1     Emerging technological advancements  55

5.2.1.2     Increasing prevalence of complex and rare genetic disorders                56

5.2.1.3     Growing demand for high-throughput sequencing 56

5.2.1.4     Expanding applications of long-read sequencing   57

5.2.2        RESTRAINTS             57

5.2.2.1     High investment cost               57

5.2.2.2     Technical limitations of existing technologies         58

5.2.3        OPPORTUNITIES      58

5.2.3.1     Rising adoption in clinical genomics       58

5.2.4        CHALLENGES           58

5.2.4.1     Data preservation, analysis, and validation issues 58

5.3            TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES           59

5.4            REGULATORY LANDSCAPE      59

5.4.1        REGULATORY SCENARIO         59

5.4.2        REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS  60

5.5            VALUE CHAIN ANALYSIS           62

5.6            TECHNOLOGICAL ANALYSIS    64

5.6.1        KEY TECHNOLOGIES                64

5.6.1.1     Single-molecule real-time sequencing    64

5.6.1.2     Nanopore sequencing              65

5.6.1.3     Synthetic long-read sequencing               65

5.6.2        COMPLEMENTARY TECHNOLOGIES        66

5.6.2.1     Next-generation sequencing combined with artificial intelligence          66

5.6.2.2     Single-cell sequencing             66

5.6.2.3     Polymerase chain reaction     66

5.6.3        ADJACENT TECHNOLOGIES     67

5.6.3.1     Sample preparation technologies           67

5.6.3.2     Data analysis           67

5.7            PRICING ANALYSIS  68

5.7.1        AVERAGE SELLING PRICE OF KEY PLAYERS, BY OFFERING    68

5.7.2        AVERAGE SELLING PRICE OF KEY PLAYERS, BY INSTRUMENT                68

5.7.3        AVERAGE SELLING PRICE OF KEY PLAYERS, BY CONSUMABLE              69

5.7.4        AVERAGE SELLING PRICE OF KEY PLAYERS, BY SERVICE       70

5.7.5        AVERAGE SELLING PRICE, BY REGION    71

5.8            PATENT ANALYSIS   72

5.9            SUPPLY CHAIN ANALYSIS        74

5.10         ECOSYSTEM ANALYSIS            75

5.11         KEY CONFERENCES & EVENTS, 2024–2025         77

5.12         PORTER’S FIVE FORCES ANALYSIS          78

5.12.1      PORTER’S FIVE FORCES ANALYSIS          78

5.12.2      INTENSITY OF COMPETITIVE RIVALRY     79

5.12.3      BARGAINING POWER OF SUPPLIERS      79

5.12.4      BARGAINING POWER OF BUYERS            79

5.12.5      THREAT OF SUBSTITUTES        79

5.12.6      THREAT OF NEW ENTRANTS   79

5.13         KEY STAKEHOLDERS & BUYING CRITERIA               80

5.13.1      KEY STAKEHOLDERS IN BUYING PROCESS             80

5.13.2      KEY BUYING CRITERIA, BY END USER     80

5.14         INVESTMENT & FUNDING SCENARIO      82

5.15         CASE STUDY ANALYSIS            82

5.15.1      ENHANCED DETECTION OF AMYOTROPHIC LATERAL SCLEROSIS USING PACBIO SINGLE-MOLECULE, REAL-TIME SEQUENCING    82

5.15.2      IMPROVED DIAGNOSIS OF RARE DISEASES WITH LONG-READ WHOLE-GENOME SEQUENCING           83

5.16         IMPACT OF AI ON LONG-READ SEQUENCING MARKET            83

6               LONG-READ SEQUENCING MARKET, BY OFFERING                 84

6.1            INTRODUCTION        85

6.2            CONSUMABLES       85

6.2.1        LARGE NUMBER OF PLAYERS OPERATING IN CONSUMABLES SPACE TO PROPEL DEMAND                  85

6.3            INSTRUMENTS         88

6.3.1        ADVANCEMENTS IN LONG-READ SEQUENCING TECHNOLOGY TO BOOST MARKET GROWTH 88

6.4            SERVICES                 91

6.4.1        RISING DEMAND FOR COMPREHENSIVE GENOMIC DATA IN CLINICAL GENOMICS TO FAVOR MARKET GROWTH       91

7               LONG-READ SEQUENCING MARKET, BY TECHNOLOGY           95

7.1            INTRODUCTION        96

7.2            NANOPORE SEQUENCING       96

7.2.1        DIRECT DETECTION OF DNA MODIFICATIONS DURING SEQUENCING TO DRIVE MARKET GROWTH 96

7.3            SINGLE-MOLECULE REAL-TIME SEQUENCING         100

7.3.1        HIGHLY ACCURATE LONG READS BY REPEATEDLY SEQUENCING CIRCULARIZED DNA TO DRIVE DEMAND       100

7.4            SYNTHETIC LONG-READ SEQUENCING   103

7.4.1        GROWING DEMAND FOR DETAILED AND COMPREHENSIVE GENOMIC DATA IN AREAS SUCH AS CLINICAL GENOMICS TO BOOST MARKET                 103

8               LONG-READ SEQUENCING MARKET, BY WORKFLOW              106

8.1            INTRODUCTION        107

8.2            SEQUENCING           107

8.2.1        DIRECT DETECTION OF DNA MODIFICATIONS DURING SEQUENCING TO DRIVE MARKET GROWTH 107

8.3            SAMPLE PREPARATION            111

8.3.1        DEVELOPMENT OF ADVANCED LIBRARY PREPARATION SOLUTIONS TO BOOST MARKET                  111

8.4            DATA ANALYSIS       114

8.4.1        DEVELOPMENT OF ADVANCED BIOINFORMATICS SOLUTIONS TO FAVOR MARKET GROWTH 114

9               LONG-READ SEQUENCING MARKET, BY APPLICATION            118

9.1            INTRODUCTION        119

9.2            WHOLE-GENOME SEQUENCING               119

9.2.1        INCREASING USE OF WGS IN RARE DISEASE RESEARCH TO DRIVE MARKET GROWTH                  119

9.3            TARGETED SEQUENCING         123

9.3.1        RISING DEMAND FOR LONG-READ SEQUENCING IN DISEASE DIAGNOSTICS TO SUPPORT MARKET GROWTH   123

9.4            METAGENOMICS     126

9.4.1        GROWING DEMAND FOR HIGH-RESOLUTION AND ACCURATE METAGENOMIC DATA TO FUEL GROWTH         126

9.5            EPIGENETICS           129

9.5.1        ADVANTAGES OF LRS IN EPIGENETICS STUDIES TO BOOST DEMAND   129

9.6            WHOLE-EXOME SEQUENCING 132

9.6.1        GROWING DEMAND FOR PRECISION GENETICS TO FAVOR MARKET GROWTH      132

9.7            OTHER APPLICATIONS             135

10             LONG-READ SEQUENCING MARKET, BY USAGE      138

10.1         INTRODUCTION        139

10.2         RESEARCH USAGE  139

10.2.1      RISING RESEARCH COLLABORATIONS TO BOOST MARKET GROWTH    139

10.3         CLINICAL USAGE      142

10.3.1      RISING PREVALENCE OF CANCER TO DRIVE MARKET GROWTH             142

11             LONG-READ SEQUENCING MARKET, BY END USER                 146

11.1         INTRODUCTION        147

11.2         ACADEMIC & RESEARCH INSTITUTES      147

11.2.1      ACADEMIC & RESEARCH INSTITUTES TO DOMINATE MARKET DURING FORECAST PERIOD                  147

11.3         PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES      151

11.3.1      GROWING COLLABORATIONS BETWEEN LRS PLAYERS AND PHARMA-BIOTECH COMPANIES TO DRIVE GROWTH              151

11.4         HOSPITALS, CLINICS, AND DIAGNOSTIC LABS         154

11.4.1      RISING DEMAND FOR LONG-READ SEQUENCING IN HOSPITALS & CLINICS TO SUPPORT GROWTH 154

11.5         OTHER END USERS 157

12             LONG-READ SEQUENCING MARKET, BY REGION    160

12.1         INTRODUCTION        161

12.2         NORTH AMERICA     162

12.2.1      US             165

12.2.1.1  US to dominate North American long-read sequencing market during forecast period                  165

12.2.2      CANADA   168

12.2.2.1  Increasing government initiatives in genomics research to aid market growth      168

12.3         EUROPE   171

12.3.1      GERMANY                 173

12.3.1.1  Increased funding for genomic development and application to favor market growth                  173

12.3.2      UK            176

12.3.2.1  Favorable NHS funding and increased number of patients with rare genetic diseases to spur market growth 176

12.3.3      FRANCE   179

12.3.3.1  Increasing government investment in genomics and proteomics research to augment market growth         179

12.3.4      ITALY        181

12.3.4.1  Developed research infrastructure and increased genomics investment to fuel market growth      181

12.3.5      SPAIN       184

12.3.5.1  Advancements in translational and personalized medicine sector to boost market growth                  184

12.3.6      REST OF EUROPE    186

12.4         ASIA PACIFIC            189

12.4.1      CHINA      193

12.4.1.1  Favorable regulatory reforms and high patient population to aid market growth  193

12.4.2      JAPAN      196

12.4.2.1  Technological advancements and high government investments in biotechnology to augment market growth          196

12.4.3      INDIA        198

12.4.3.1  Favorable government initiatives for genomics research to drive market              198

12.4.4      SOUTH KOREA         201

12.4.4.1  Rising government investments in cancer treatments and precision medicine to support market growth         201

12.4.5      REST OF ASIA PACIFIC              203

12.5         LATIN AMERICA        206

12.5.1      BRAZIL     209

12.5.1.1  Increased public and private investments in sequencing technologies to spur market growth      209

12.5.2      MEXICO   211

12.5.2.1  Growing prevalence of chronic disease and increasing geriatric population to support market growth         211

12.5.3      ARGENTINA               213

12.5.3.1  Rising healthcare investments and increasing focus on public health services to propel market growth         213

12.5.4      REST OF LATIN AMERICA         216

12.6         MIDDLE EAST           218

12.6.1      GCC COUNTRIES      221

12.6.1.1  Saudi Arabia             223

12.6.1.1.1                High government healthcare expenditure and technological advancements to boost market growth                223

12.6.1.2  UAE           226

12.6.1.2.1                Increasing R&D investment and growing healthcare infrastructure to aid market growth      226

12.6.1.3  Rest of GCC Countries             229

12.6.2      REST OF MIDDLE EAST            231

12.7         AFRICA     234

12.7.1      GROWING FOCUS ON PRECISION MEDICINE TO PROPEL MARKET GROWTH         234

13             COMPETITIVE LANDSCAPE      237

13.1         INTRODUCTION        237

13.2         KEY PLAYER STRATEGY/RIGHT TO WIN  237

13.3         REVENUE ANALYSIS                 239

13.4         MARKET SHARE ANALYSIS      240

13.5         COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023            243

13.5.1      STARS      243

13.5.2      EMERGING LEADERS               243

13.5.3      PERVASIVE PLAYERS                243

13.5.4      PARTICIPANTS         243

13.5.5      COMPANY FOOTPRINT: KEY PLAYERS, 2023          245

13.5.5.1  Company footprint  245

13.5.5.2  Region footprint       245

13.5.5.3  Offering footprint     246

13.5.5.4  Application footprint                 247

13.5.5.5  Technology footprint                 247

13.6         COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023     248

13.6.1      PROGRESSIVE COMPANIES    248

13.6.2      RESPONSIVE COMPANIES       248

13.6.3      DYNAMIC COMPANIES             248

13.6.4      STARTING BLOCKS 248

13.6.5      COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023     249

13.7         COMPANY VALUATION & FINANCIAL METRICS        250

13.8         BRAND/SERVICE COMPARISON              252

13.8.1      OXFORD NANOPORE TECHNOLOGIES PLC              252

13.8.2      PACBIO    253

13.8.3      ILLUMINA, INC.         253

13.8.4      AGILENT TECHNOLOGIES, INC.                 253

13.8.5      THERMO FISHER SCIENTIFIC INC.            253

13.9         COMPETITIVE SCENARIO         253

13.9.1      DEALS      253

13.9.2      EXPANSIONS            254

14             COMPANY PROFILES                255

14.1         KEY PLAYERS           255

14.1.1      OXFORD NANOPORE TECHNOLOGIES PLC              255

14.1.1.1  Business overview  255

14.1.1.2  Products & services offered   256

14.1.1.3  Recent developments              257

14.1.1.3.1                Deals       257

14.1.1.4  MnM view                 258

14.1.1.4.1                Right to win              258

14.1.1.4.2                Strategic choices     258

14.1.1.4.3                Weaknesses and competitive threats    258

14.1.2      PACBIO    259

14.1.2.1  Business overview  259

14.1.2.2  Products & services offered   260

14.1.2.3  Recent developments              262

14.1.2.3.1                Product & service launches    262

14.1.2.3.2                Deals       262

14.1.2.3.3                Expansions               263

14.1.2.3.4                Other developments                263

14.1.2.4  MnM view                 264

14.1.2.4.1                Right to win              264

14.1.2.4.2                Strategic choices     264

14.1.2.4.3                Weaknesses and competitive threats    264

14.1.3      ILLUMINA, INC.         265

14.1.3.1  Business overview  265

14.1.3.2  Products & services offered   266

14.1.3.3  Recent developments              267

14.1.3.3.1                Product launches    267

14.1.3.4  MnM view                 268

14.1.3.4.1                Key strengths           268

14.1.3.4.2                Strategic choices     268

14.1.3.4.3                Weaknesses and competitive threats    268

14.1.4      AGILENT TECHNOLOGIES, INC.                 269

14.1.4.1  Business overview  269

14.1.4.2  Products & services offered   270

14.1.5      THERMO FISHER SCIENTIFIC INC.            272

14.1.5.1  Business overview  272

14.1.5.2  Products & services offered   273

14.1.6      10X GENOMICS, INC.                275

14.1.6.1  Business overview  275

14.1.6.2  Products & services offered   276

14.1.6.3  Recent developments              277

14.1.6.3.1                Product launches    277

14.1.7      QIAGEN    278

14.1.7.1  Business overview  278

14.1.7.2  Products & services offered   279

14.1.7.3  Recent developments              280

14.1.7.3.1                Expansions               280

14.1.8      BGI GROUP               281

14.1.8.1  Business overview  281

14.1.8.2  Products & services offered   281

14.1.9      AZENTA US, INC.      282

14.1.9.1  Business overview  282

14.1.9.2  Products & services offered   283

14.1.9.3  Recent developments              284

14.1.9.3.1                Expansions               284

14.1.10   TAKARA BIO INC.      285

14.1.10.1                 Business overview  285

14.1.10.2                 Products & services offered   286

14.1.10.3                 Recent developments              287

14.1.10.3.1              Deals       287

14.1.11   NOVOGENE CO., LTD.               288

14.1.11.1                 Business overview  288

14.1.11.2                 Products & services offered   288

14.1.11.3                 Recent developments              289

14.1.11.3.1              Other developments                289

14.1.12   REVVITY INC.            290

14.1.12.1                 Business overview  290

14.1.12.2                 Products & services offered   291

14.1.13   DANAHER CORPORATION        292

14.1.13.1                 Business overview  292

14.1.13.2                 Products & services offered   293

14.1.14   NEW ENGLAND BIOLABS         294

14.1.14.1                 Business overview  294

14.1.14.2                 Products & services offered   294

14.1.15   BASE CLEAR BV       295

14.1.15.1                 Business overview  295

14.1.15.2                 Products & services offered   295

14.2         OTHER PLAYERS      296

14.2.1      ELEMENT BIOSCIENCES          296

14.2.2      GRANDOMICS          296

14.2.3      CD GENOMICS         297

14.2.4      SAGE SCIENCES, INC.               298

14.2.5      EDENROC SCIENCES                298

15             APPENDIX                 299

15.1         DISCUSSION GUIDE 299

15.2         KNOWLEDGESTORE: MARKETSANDMARKETS’  SUBSCRIPTION PORTAL             303

15.3         CUSTOMIZATION OPTIONS      305

15.4         RELATED REPORTS 305

15.5         AUTHOR DETAILS     306

LIST OF TABLES

TABLE 1   INCLUSIONS & EXCLUSIONS   32

TABLE 2   IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS        43

TABLE 3   LONG-READ SEQUENCING MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS  55

TABLE 4   US FOOD AND DRUG ADMINISTRATION: MEDICAL DEVICE CLASSIFICATION          60

TABLE 5   US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS     60

TABLE 6   NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS      60

TABLE 7   EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS                  61

TABLE 8   ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS      61

TABLE 9   REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS      62

TABLE 10 AVERAGE SELLING PRICE OF KEY PLAYERS, BY INSTRUMENT, 2021–2023 (USD)                  68

TABLE 11 AVERAGE SELLING PRICE OF KEY PLAYERS, BY CONSUMABLE, 2021–2023 (USD)                  69

TABLE 12 AVERAGE SELLING PRICE OF KEY PLAYERS, BY SERVICE, 2023 (USD) 70

TABLE 13 AVERAGE SELLING PRICE, BY REGION, 2021–2023 (USD)   71

TABLE 14 INNOVATIONS AND PATENT REGISTRATIONS, 2020–2024   73

TABLE 15 LONG-READ SEQUENCING MARKET: ROLE OF COMPANIES IN ECOSYSTEM          76

TABLE 16 LONG-READ SEQUENCING MARKET: KEY CONFERENCES & EVENTS, 2024–2025                  77

TABLE 17 LONG-READ SEQUENCING MARKET: IMPACT OF PORTER’S FIVE FORCES              78

TABLE 18 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING (%)             80

TABLE 19 KEY BUYING CRITERIA, BY END USER     81

TABLE 20 LONG-READ SEQUENCING MARKET, BY OFFERING, 2022–2029 (USD MILLION) 85

TABLE 21 LONG-READ SEQUENCING CONSUMABLES MARKET, BY REGION,

2022–2029 (USD MILLION)   86

TABLE 22 NORTH AMERICA: LONG-READ SEQUENCING CONSUMABLES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)              86

TABLE 23 EUROPE: LONG-READ SEQUENCING CONSUMABLES MARKET, BY COUNTRY,  2022–2029 (USD MILLION)                86

TABLE 24 ASIA PACIFIC: LONG-READ SEQUENCING CONSUMABLES MARKET, BY COUNTRY,  2022–2029 (USD MILLION)                87

TABLE 25 LATIN AMERICA: LONG-READ SEQUENCING CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)   87

TABLE 26 MIDDLE EAST: LONG-READ SEQUENCING CONSUMABLES MARKET, BY COUNTRY,  2022–2029 (USD MILLION)   87

TABLE 27 GCC COUNTRIES: LONG-READ SEQUENCING CONSUMABLES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)              88

TABLE 28 LONG-READ SEQUENCING INSTRUMENTS MARKET, BY REGION,

2022–2029 (USD MILLION)   89

TABLE 29 NORTH AMERICA: LONG-READ SEQUENCING INSTRUMENTS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)              89

TABLE 30 EUROPE: LONG-READ SEQUENCING INSTRUMENTS MARKET, BY COUNTRY,

2022–2029 (USD MILLION)   89

TABLE 31 ASIA PACIFIC: LONG-READ SEQUENCING INSTRUMENTS MARKET, BY COUNTRY,  2022–2029 (USD MILLION)                90

TABLE 32 LATIN AMERICA: LONG-READ SEQUENCING INSTRUMENTS MARKET, BY COUNTRY,  2022–2029 (USD MILLION)   90

TABLE 33 MIDDLE EAST: LONG-READ SEQUENCING INSTRUMENTS MARKET, BY COUNTRY,  2022–2029 (USD MILLION)                90

TABLE 34 GCC COUNTRIES: LONG-READ SEQUENCING INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)   91

TABLE 35 LONG-READ SEQUENCING SERVICES MARKET, BY REGION,

2022–2029 (USD MILLION)   92

TABLE 36 NORTH AMERICA: LONG-READ SEQUENCING SERVICES MARKET, BY COUNTRY,  2022–2029 (USD MILLION)                92

TABLE 37 EUROPE: LONG-READ SEQUENCING SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)   92

TABLE 38 ASIA PACIFIC: LONG-READ SEQUENCING SERVICES MARKET, BY COUNTRY,

2022–2029 (USD MILLION)   93

TABLE 39 LATIN AMERICA: LONG-READ SEQUENCING SERVICES MARKET, BY COUNTRY,  2022–2029 (USD MILLION)                93

TABLE 40 MIDDLE EAST: LONG-READ SEQUENCING SERVICES MARKET, BY COUNTRY,  2022–2029 (USD MILLION)                93

TABLE 41 GCC COUNTRIES: LONG-READ SEQUENCING SERVICES MARKET, BY COUNTRY,  2022–2029 (USD MILLION)                94

TABLE 42 LONG-READ SEQUENCING MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)                  96

TABLE 43 LONG-READ SEQUENCING MARKET FOR NANOPORE SEQUENCING, BY REGION,  2022–2029 (USD MILLION)                97

TABLE 44 NORTH AMERICA: LONG-READ SEQUENCING MARKET FOR NANOPORE SEQUENCING,  BY COUNTRY, 2022–2029 (USD MILLION)              97

TABLE 45 EUROPE: LONG-READ SEQUENCING MARKET FOR NANOPORE SEQUENCING,

BY COUNTRY, 2022–2029 (USD MILLION)              98

TABLE 46 ASIA PACIFIC: LONG-READ SEQUENCING MARKET FOR NANOPORE SEQUENCING,  BY COUNTRY, 2022–2029 (USD MILLION)  98

TABLE 47 LATIN AMERICA: LONG-READ SEQUENCING MARKET FOR NANOPORE SEQUENCING,  BY COUNTRY, 2022–2029 (USD MILLION)  99

TABLE 48 MIDDLE EAST: LONG-READ SEQUENCING MARKET FOR NANOPORE SEQUENCING,  BY COUNTRY, 2022–2029 (USD MILLION)  99

TABLE 49 GCC COUNTRIES: LONG-READ SEQUENCING MARKET FOR NANOPORE SEQUENCING,  BY COUNTRY, 2022–2029 (USD MILLION)  99

TABLE 50 LONG-READ SEQUENCING MARKET FOR SINGLE-MOLECULE REAL-TIME SEQUENCING,  BY REGION, 2022–2029 (USD MILLION)                 100

TABLE 51 NORTH AMERICA: LONG-READ SEQUENCING MARKET FOR SINGLE-MOLECULE REAL-TIME SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)     101

TABLE 52 EUROPE: LONG-READ SEQUENCING MARKET FOR SINGLE-MOLECULE REAL-TIME SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)     101

TABLE 53 ASIA PACIFIC: LONG-READ SEQUENCING MARKET FOR SINGLE-MOLECULE REAL-TIME SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)     101

TABLE 54 LATIN AMERICA: LONG-READ SEQUENCING MARKET FOR SINGLE-MOLECULE REAL-TIME SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)     102

TABLE 55 MIDDLE EAST: LONG-READ SEQUENCING MARKET FOR SINGLE-MOLECULE REAL-TIME SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)     102

TABLE 56 GCC COUNTRIES: LONG-READ SEQUENCING MARKET FOR SINGLE-MOLECULE REAL-TIME SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)     102

TABLE 57 LONG-READ SEQUENCING MARKET FOR SYNTHETIC LONG-READ SEQUENCING,

BY REGION, 2022–2029 (USD MILLION)                 103

TABLE 58 NORTH AMERICA: LONG-READ SEQUENCING MARKET FOR SYNTHETIC LONG-READ SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)     104

TABLE 59 EUROPE: LONG-READ SEQUENCING MARKET FOR SYNTHETIC LONG-READ SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)              104

TABLE 60 ASIA PACIFIC: LONG-READ SEQUENCING MARKET FOR SYNTHETIC LONG-READ SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)     104

TABLE 61 LATIN AMERICA: LONG-READ SEQUENCING MARKET FOR SYNTHETIC LONG-READ SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)     105

TABLE 62 MIDDLE EAST: LONG-READ SEQUENCING MARKET FOR SYNTHETIC LONG-READ SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)     105

TABLE 63 GCC COUNTRIES: LONG-READ SEQUENCING MARKET FOR SYNTHETIC LONG-READ SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)     105

TABLE 64 LONG-READ SEQUENCING MARKET, BY WORKFLOW, 2022–2029 (USD MILLION)                  107

TABLE 65 LONG-READ SEQUENCING MARKET FOR SEQUENCING WORKFLOWS, BY REGION,  2022–2029 (USD MILLION)   108

TABLE 66 NORTH AMERICA: LONG-READ SEQUENCING MARKET FOR SEQUENCING WORKFLOWS, BY COUNTRY, 2022–2029 (USD MILLION)              108

TABLE 67 EUROPE: LONG-READ SEQUENCING MARKET FOR SEQUENCING WORKFLOWS,

BY COUNTRY, 2022–2029 (USD MILLION)              109

TABLE 68 ASIA PACIFIC: LONG-READ SEQUENCING MARKET FOR SEQUENCING WORKFLOWS,  BY COUNTRY, 2022–2029 (USD MILLION)  109

TABLE 69 LATIN AMERICA: LONG-READ SEQUENCING MARKET FOR SEQUENCING WORKFLOWS,  BY COUNTRY, 2022–2029 (USD MILLION)              110

TABLE 70 MIDDLE EAST: LONG-READ SEQUENCING MARKET FOR SEQUENCING WORKFLOWS,  BY COUNTRY, 2022–2029 (USD MILLION)  110

TABLE 71 GCC COUNTRIES: LONG-READ SEQUENCING MARKET FOR SEQUENCING WORKFLOWS,  BY COUNTRY, 2022–2029 (USD MILLION)              110

TABLE 72 LONG-READ SEQUENCING MARKET FOR SAMPLE PREPARATION WORKFLOWS,

BY REGION, 2022–2029 (USD MILLION)                 112

TABLE 73 NORTH AMERICA: LONG-READ SEQUENCING MARKET FOR SAMPLE PREPARATION WORKFLOWS, BY COUNTRY, 2022–2029 (USD MILLION)     112

TABLE 74 EUROPE: LONG-READ SEQUENCING MARKET FOR SAMPLE PREPARATION WORKFLOWS, BY COUNTRY, 2022–2029 (USD MILLION)              112

TABLE 75 ASIA PACIFIC: LONG-READ SEQUENCING MARKET FOR SAMPLE PREPARATION WORKFLOWS, BY COUNTRY, 2022–2029 (USD MILLION)     113

TABLE 76 LATIN AMERICA: LONG-READ SEQUENCING MARKET FOR SAMPLE PREPARATION WORKFLOWS, BY COUNTRY, 2022–2029 (USD MILLION)     113

TABLE 77 MIDDLE EAST: LONG-READ SEQUENCING MARKET FOR SAMPLE PREPARATION WORKFLOWS, BY COUNTRY, 2022–2029 (USD MILLION)     113

TABLE 78 GCC COUNTRIES: LONG-READ SEQUENCING MARKET FOR SAMPLE PREPARATION WORKFLOWS, BY COUNTRY, 2022–2029 (USD MILLION)     114

TABLE 79 LONG-READ SEQUENCING MARKET FOR DATA ANALYSIS WORKFLOWS,

BY REGION, 2022–2029 (USD MILLION)                 115

TABLE 80 NORTH AMERICA: LONG-READ SEQUENCING MARKET FOR DATA ANALYSIS WORKFLOWS, BY COUNTRY, 2022–2029 (USD MILLION)              115

TABLE 81 EUROPE: LONG-READ SEQUENCING MARKET FOR DATA ANALYSIS WORKFLOWS,  BY COUNTRY, 2022–2029 (USD MILLION)  115

TABLE 82 ASIA PACIFIC: LONG-READ SEQUENCING MARKET FOR DATA ANALYSIS WORKFLOWS,  BY COUNTRY, 2022–2029 (USD MILLION)  116

TABLE 83 LATIN AMERICA: LONG-READ SEQUENCING MARKET FOR DATA ANALYSIS WORKFLOWS, BY COUNTRY, 2022–2029 (USD MILLION)              116

TABLE 84 MIDDLE EAST: LONG-READ SEQUENCING MARKET FOR DATA ANALYSIS WORKFLOWS,  BY COUNTRY, 2022–2029 (USD MILLION)              116

TABLE 85 GCC COUNTRIES: LONG-READ SEQUENCING MARKET FOR DATA ANALYSIS WORKFLOWS, BY COUNTRY, 2022–2029 (USD MILLION)              117

TABLE 86 LONG-READ SEQUENCING MARKET, BY APPLICATION, 2022–2029 (USD MILLION)                  119

TABLE 87 LONG-READ SEQUENCING MARKET FOR WHOLE-GENOME SEQUENCING, BY REGION, 2022–2029 (USD MILLION)   120

TABLE 88 NORTH AMERICA: LONG-READ SEQUENCING MARKET FOR WHOLE-GENOME SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)     120

TABLE 89 EUROPE: LONG-READ SEQUENCING MARKET FOR WHOLE-GENOME SEQUENCING,  BY COUNTRY, 2022–2029 (USD MILLION)  121

TABLE 90 ASIA PACIFIC: LONG-READ SEQUENCING MARKET FOR WHOLE-GENOME SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)  121

TABLE 91 LATIN AMERICA: LONG-READ SEQUENCING MARKET FOR WHOLE-GENOME SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)              122

TABLE 92 MIDDLE EAST: LONG-READ SEQUENCING MARKET FOR WHOLE-GENOME SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)              122

TABLE 93 GCC COUNTRIES: LONG-READ SEQUENCING MARKET FOR WHOLE-GENOME SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)              122

TABLE 94 LONG-READ SEQUENCING MARKET FOR TARGETED SEQUENCING, BY REGION,  2022–2029 (USD MILLION)                123

TABLE 95 NORTH AMERICA: LONG-READ SEQUENCING MARKET FOR TARGETED SEQUENCING,  BY COUNTRY, 2022–2029 (USD MILLION)  124

TABLE 96 EUROPE: LONG-READ SEQUENCING MARKET FOR TARGETED SEQUENCING,

BY COUNTRY, 2022–2029 (USD MILLION)              124

TABLE 97 ASIA PACIFIC: LONG-READ SEQUENCING MARKET FOR TARGETED SEQUENCING,  BY COUNTRY, 2022–2029 (USD MILLION)  124

TABLE 98 LATIN AMERICA: LONG-READ SEQUENCING MARKET FOR TARGETED SEQUENCING,  BY COUNTRY, 2022–2029 (USD MILLION)  125

TABLE 99 MIDDLE EAST: LONG-READ SEQUENCING MARKET FOR TARGETED SEQUENCING,  BY COUNTRY, 2022–2029 (USD MILLION)  125

TABLE 100               GCC COUNTRIES: LONG-READ SEQUENCING MARKET FOR TARGETED SEQUENCING,  BY COUNTRY, 2022–2029 (USD MILLION)  125

TABLE 101               LONG-READ SEQUENCING MARKET FOR METAGENOMICS, BY REGION,

2022–2029 (USD MILLION)   126

TABLE 102               NORTH AMERICA: LONG-READ SEQUENCING MARKET FOR METAGENOMICS,

BY COUNTRY, 2022–2029 (USD MILLION)              127

TABLE 103               EUROPE: LONG-READ SEQUENCING MARKET FOR METAGENOMICS, BY COUNTRY,  2022–2029 (USD MILLION)                127

TABLE 104               ASIA PACIFIC: LONG-READ SEQUENCING MARKET FOR METAGENOMICS,

BY COUNTRY, 2022–2029 (USD MILLION)              127

TABLE 105               LATIN AMERICA: LONG-READ SEQUENCING MARKET FOR METAGENOMICS,

BY COUNTRY, 2022–2029 (USD MILLION)              128

TABLE 106               MIDDLE EAST: LONG-READ SEQUENCING MARKET FOR METAGENOMICS,

BY COUNTRY, 2022–2029 (USD MILLION)              128

TABLE 107               GCC COUNTRIES: LONG-READ SEQUENCING MARKET FOR METAGENOMICS,

BY COUNTRY, 2022–2029 (USD MILLION)              128

TABLE 108               LONG-READ SEQUENCING MARKET FOR EPIGENETICS, BY REGION,

2022–2029 (USD MILLION)   129

TABLE 109               NORTH AMERICA: LONG-READ SEQUENCING MARKET FOR EPIGENETICS,

BY COUNTRY, 2022–2029 (USD MILLION)              130

TABLE 110               EUROPE: LONG-READ SEQUENCING MARKET FOR EPIGENETICS, BY COUNTRY,  2022–2029 (USD MILLION)   130

TABLE 111               ASIA PACIFIC: LONG-READ SEQUENCING MARKET FOR EPIGENETICS, BY COUNTRY, 2022–2029 (USD MILLION)  130

TABLE 112               LATIN AMERICA: LONG-READ SEQUENCING MARKET FOR EPIGENETICS,

BY COUNTRY, 2022–2029 (USD MILLION)              131

TABLE 113               MIDDLE EAST: LONG-READ SEQUENCING MARKET FOR EPIGENETICS,

BY COUNTRY, 2022–2029 (USD MILLION)              131

TABLE 114               GCC COUNTRIES: LONG-READ SEQUENCING MARKET FOR EPIGENETICS,

BY COUNTRY, 2022–2029 (USD MILLION)              131

TABLE 115               LONG-READ SEQUENCING MARKET FOR WHOLE-EXOME SEQUENCING, BY REGION, 2022–2029 (USD MILLION)     132

TABLE 116               NORTH AMERICA: LONG-READ SEQUENCING MARKET FOR WHOLE-EXOME SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)     132

TABLE 117              EUROPE: LONG-READ SEQUENCING MARKET FOR WHOLE-EXOME SEQUENCING,  BY COUNTRY, 2022–2029 (USD MILLION)              133

TABLE 118               ASIA PACIFIC: LONG-READ SEQUENCING MARKET FOR WHOLE-EXOME SEQUENCING,  BY COUNTRY, 2022–2029 (USD MILLION)  133

TABLE 119               LATIN AMERICA: LONG-READ SEQUENCING MARKET FOR WHOLE-EXOME SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)     134

TABLE 120               MIDDLE EAST: LONG-READ SEQUENCING MARKET FOR WHOLE-EXOME SEQUENCING,  BY COUNTRY, 2022–2029 (USD MILLION)  134

TABLE 121               GCC COUNTRIES: LONG-READ SEQUENCING MARKET FOR WHOLE-EXOME SEQUENCING, BY COUNTRY, 2022–2029 (USD MILLION)     134

TABLE 122               LONG-READ SEQUENCING MARKET FOR OTHER APPLICATIONS, BY REGION,  2022–2029 (USD MILLION)   135

TABLE 123               NORTH AMERICA: LONG-READ SEQUENCING MARKET FOR OTHER APPLICATIONS,  BY COUNTRY, 2022–2029 (USD MILLION) 136

TABLE 124               EUROPE: LONG-READ SEQUENCING MARKET FOR OTHER APPLICATIONS,

BY COUNTRY, 2022–2029 (USD MILLION)              136

TABLE 125               ASIA PACIFIC: LONG-READ SEQUENCING MARKET FOR OTHER APPLICATIONS,

BY COUNTRY, 2022–2029 (USD MILLION)              136

TABLE 126              LATIN AMERICA: LONG-READ SEQUENCING MARKET FOR OTHER APPLICATIONS,  BY COUNTRY, 2022–2029 (USD MILLION)              137

TABLE 127               MIDDLE EAST: LONG-READ SEQUENCING MARKET FOR OTHER APPLICATIONS,

BY COUNTRY, 2022–2029 (USD MILLION)              137

TABLE 128               GCC COUNTRIES: LONG-READ SEQUENCING MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)    137

TABLE 129               LONG-READ SEQUENCING MARKET, BY USAGE, 2022–2029 (USD MILLION)                  139

TABLE 130               LONG-READ SEQUENCING MARKET FOR RESEARCH USAGE, BY REGION,

2022–2029 (USD MILLION)   140

TABLE 131               NORTH AMERICA: LONG-READ SEQUENCING MARKET FOR RESEARCH USAGE,

BY COUNTRY, 2022–2029 (USD MILLION)              140

TABLE 132               EUROPE: LONG-READ SEQUENCING MARKET FOR RESEARCH USAGE,

BY COUNTRY, 2022–2029 (USD MILLION)              140

TABLE 133               ASIA PACIFIC: LONG-READ SEQUENCING MARKET FOR RESEARCH USAGE,

BY COUNTRY, 2022–2029 (USD MILLION)              141

TABLE 134               LATIN AMERICA: LONG-READ SEQUENCING MARKET FOR RESEARCH USAGE,

BY COUNTRY, 2022–2029 (USD MILLION)              141

TABLE 135               MIDDLE EAST: LONG-READ SEQUENCING MARKET FOR RESEARCH USAGE,

BY COUNTRY, 2022–2029 (USD MILLION)              141

TABLE 136               GCC COUNTRIES: LONG-READ SEQUENCING MARKET FOR RESEARCH USAGE,

BY COUNTRY, 2022–2029 (USD MILLION)              142

TABLE 137               LONG-READ SEQUENCING MARKET FOR CLINICAL USAGE, BY REGION,

2022–2029 (USD MILLION)   143

TABLE 138               NORTH AMERICA: LONG-READ SEQUENCING MARKET FOR CLINICAL USAGE,

BY COUNTRY, 2022–2029 (USD MILLION)              143

TABLE 139               EUROPE: LONG-READ SEQUENCING MARKET FOR CLINICAL USAGE, BY COUNTRY,  2022–2029 (USD MILLION)                143

TABLE 140               ASIA PACIFIC: LONG-READ SEQUENCING MARKET FOR CLINICAL USAGE,

BY COUNTRY, 2022–2029 (USD MILLION)              144

TABLE 141               LATIN AMERICA: LONG-READ SEQUENCING MARKET FOR CLINICAL USAGE,

BY COUNTRY, 2022–2029 (USD MILLION)              144

TABLE 142               MIDDLE EAST: LONG-READ SEQUENCING MARKET FOR CLINICAL USAGE,

BY COUNTRY, 2022–2029 (USD MILLION)              144

TABLE 143               GCC COUNTRIES: LONG-READ SEQUENCING MARKET FOR CLINICAL USAGE,

BY COUNTRY, 2022–2029 (USD MILLION)              145

TABLE 144               LONG-READ SEQUENCING MARKET, BY END USER, 2022–2029 (USD MILLION)                  147

TABLE 145               LONG-READ SEQUENCING MARKET FOR ACADEMIC & RESEARCH INSTITUTES,

BY REGION, 2022–2029 (USD MILLION)                 148

TABLE 146               NORTH AMERICA: LONG-READ SEQUENCING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)      148

TABLE 147               EUROPE: LONG-READ SEQUENCING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)         149

TABLE 148               ASIA PACIFIC: LONG-READ SEQUENCING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)         149

TABLE 149               LATIN AMERICA: LONG-READ SEQUENCING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)      150

TABLE 150               MIDDLE EAST: LONG-READ SEQUENCING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)         150

TABLE 151               GCC COUNTRIES: LONG-READ SEQUENCING MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)      150

TABLE 152               LONG-READ SEQUENCING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION)           151

TABLE 153               NORTH AMERICA: LONG-READ SEQUENCING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)           152

TABLE 154               EUROPE: LONG-READ SEQUENCING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)           152

TABLE 155               ASIA PACIFIC: LONG-READ SEQUENCING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)           152

TABLE 156               LATIN AMERICA: LONG-READ SEQUENCING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)           153

TABLE 157               MIDDLE EAST: LONG-READ SEQUENCING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)           153

TABLE 158               GCC COUNTRIES: LONG-READ SEQUENCING MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)           153

TABLE 159               LONG-READ SEQUENCING MARKET FOR HOSPITALS, CLINICS, AND DIAGNOSTIC LABS,  BY REGION, 2022–2029 (USD MILLION)  154

TABLE 160               NORTH AMERICA: LONG-READ SEQUENCING MARKET FOR HOSPITALS, CLINICS, AND DIAGNOSTIC LABS, BY COUNTRY, 2022–2029 (USD MILLION)      155

TABLE 161               EUROPE: LONG-READ SEQUENCING MARKET FOR HOSPITALS, CLINICS, AND DIAGNOSTIC LABS, BY COUNTRY, 2022–2029 (USD MILLION)              155

TABLE 162               ASIA PACIFIC: LONG-READ SEQUENCING MARKET FOR HOSPITALS, CLINICS, AND DIAGNOSTIC LABS, BY COUNTRY, 2022–2029 (USD MILLION)      155

TABLE 163               LATIN AMERICA: LONG-READ SEQUENCING MARKET FOR HOSPITALS, CLINICS, AND DIAGNOSTIC LABS, BY COUNTRY, 2022–2029 (USD MILLION)      156

TABLE 164               MIDDLE EAST: LONG-READ SEQUENCING MARKET FOR HOSPITALS, CLINICS, AND DIAGNOSTIC LABS, BY COUNTRY, 2022–2029 (USD MILLION)      156

TABLE 165               GCC COUNTRIES: LONG-READ SEQUENCING MARKET FOR HOSPITALS, CLINICS, AND DIAGNOSTIC LABS, BY COUNTRY, 2022–2029 (USD MILLION)      156

TABLE 166               LONG-READ SEQUENCING MARKET FOR OTHER END USERS, BY REGION,

2022–2029 (USD MILLION)   157

TABLE 167               NORTH AMERICA: LONG-READ SEQUENCING MARKET FOR OTHER END USERS,

BY COUNTRY, 2022–2029 (USD MILLION)              158

TABLE 168               EUROPE: LONG-READ SEQUENCING MARKET FOR OTHER END USERS,

BY COUNTRY, 2022–2029 (USD MILLION)              158

TABLE 169               ASIA PACIFIC: LONG-READ SEQUENCING MARKET FOR OTHER END USERS,

BY COUNTRY, 2022–2029 (USD MILLION)              158

TABLE 170               LATIN AMERICA: LONG-READ SEQUENCING MARKET FOR OTHER END USERS,

BY COUNTRY, 2022–2029 (USD MILLION)              159

TABLE 171               MIDDLE EAST: LONG-READ SEQUENCING MARKET FOR OTHER END USERS,

BY COUNTRY, 2022–2029 (USD MILLION)              159

TABLE 172               GCC COUNTRIES: LONG-READ SEQUENCING MARKET FOR OTHER END USERS,

BY COUNTRY, 2022–2029 (USD MILLION)              159

TABLE 173               LONG-READ SEQUENCING MARKET, BY REGION, 2022–2029 (USD MILLION)                  161

TABLE 174               NORTH AMERICA: LONG-READ SEQUENCING MARKET, BY COUNTRY,

2022–2029 (USD MILLION)   163

TABLE 175               NORTH AMERICA: LONG-READ SEQUENCING MARKET, BY OFFERING,

2022–2029 (USD MILLION)   163

TABLE 176               NORTH AMERICA: LONG-READ SEQUENCING MARKET, BY WORKFLOW,

2022–2029 (USD MILLION)   163

TABLE 177               NORTH AMERICA: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)   164

TABLE 178               NORTH AMERICA: LONG-READ SEQUENCING MARKET, BY APPLICATION,

2022–2029 (USD MILLION)   164

TABLE 179               NORTH AMERICA: LONG-READ SEQUENCING MARKET, BY USAGE,

2022–2029 (USD MILLION)   164

TABLE 180               NORTH AMERICA: LONG-READ SEQUENCING MARKET, BY END USER,

2022–2029 (USD MILLION)   165

TABLE 181               US: LONG-READ SEQUENCING MARKET, BY OFFERING, 2022–2029 (USD MILLION) 166

TABLE 182               US: LONG-READ SEQUENCING MARKET, BY WORKFLOW,

2022–2029 (USD MILLION)   166

TABLE 183               US: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)   166

TABLE 184               US: LONG-READ SEQUENCING MARKET, BY APPLICATION,

2022–2029 (USD MILLION)   167

TABLE 185               US: LONG-READ SEQUENCING MARKET, BY USAGE, 2022–2029 (USD MILLION)                  167

TABLE 186               US: LONG-READ SEQUENCING MARKET, BY END USER,

2022–2029 (USD MILLION)   167

TABLE 187               CANADA: LONG-READ SEQUENCING MARKET, BY OFFERING,

2022–2029 (USD MILLION)   169

TABLE 188               CANADA: LONG-READ SEQUENCING MARKET, BY WORKFLOW,

2022–2029 (USD MILLION)   169

TABLE 189               CANADA: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)   169

TABLE 190               CANADA: LONG-READ SEQUENCING MARKET, BY APPLICATION,

2022–2029 (USD MILLION)   170

TABLE 191               CANADA: LONG-READ SEQUENCING MARKET, BY USAGE,

2022–2029 (USD MILLION)   170

TABLE 192               CANADA: LONG-READ SEQUENCING MARKET, BY END USER,

2022–2029 (USD MILLION)   170

TABLE 193               EUROPE: LONG-READ SEQUENCING MARKET, BY COUNTRY,

2022–2029 (USD MILLION)   171

TABLE 194               EUROPE: LONG-READ SEQUENCING MARKET, BY OFFERING,

2022–2029 (USD MILLION)   171

TABLE 195               EUROPE: LONG-READ SEQUENCING MARKET, BY WORKFLOW,

2022–2029 (USD MILLION)   172

TABLE 196               EUROPE: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)   172

TABLE 197               EUROPE: LONG-READ SEQUENCING MARKET, BY APPLICATION,

2022–2029 (USD MILLION)   172

TABLE 198               EUROPE: LONG-READ SEQUENCING MARKET, BY USAGE,

2022–2029 (USD MILLION)   173

TABLE 199               EUROPE: LONG-READ SEQUENCING MARKET, BY END USER,

2022–2029 (USD MILLION)   173

TABLE 200               GERMANY: LONG-READ SEQUENCING MARKET, BY OFFERING,

2022–2029 (USD MILLION)   174

TABLE 201               GERMANY: LONG-READ SEQUENCING MARKET, BY WORKFLOW,

2022–2029 (USD MILLION)   174

TABLE 202               GERMANY: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)   175

TABLE 203               GERMANY: LONG-READ SEQUENCING MARKET, BY APPLICATION,

2022–2029 (USD MILLION)   175

TABLE 204               GERMANY: LONG-READ SEQUENCING MARKET, BY USAGE,

2022–2029 (USD MILLION)   175

TABLE 205               GERMANY: LONG-READ SEQUENCING MARKET, BY END USER,

2022–2029 (USD MILLION)   176

TABLE 206               UK: LONG-READ SEQUENCING MARKET, BY OFFERING,

2022–2029 (USD MILLION)   177

TABLE 207               UK: LONG-READ SEQUENCING MARKET, BY WORKFLOW,

2022–2029 (USD MILLION)   177

TABLE 208               UK: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)   177

TABLE 209               UK: LONG-READ SEQUENCING MARKET, BY APPLICATION,

2022–2029 (USD MILLION)   178

TABLE 210               UK: LONG-READ SEQUENCING MARKET, BY USAGE, 2022–2029 (USD MILLION)                  178

TABLE 211               UK: LONG-READ SEQUENCING MARKET, BY END USER,

2022–2029 (USD MILLION)   178

TABLE 212               FRANCE: LONG-READ SEQUENCING MARKET, BY OFFERING,

2022–2029 (USD MILLION)   179

TABLE 213               FRANCE: LONG-READ SEQUENCING MARKET, BY WORKFLOW,

2022–2029 (USD MILLION)   179

TABLE 214               FRANCE: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)   180

TABLE 215               FRANCE: LONG-READ SEQUENCING MARKET, BY APPLICATION,

2022–2029 (USD MILLION)   180

TABLE 216               FRANCE: LONG-READ SEQUENCING MARKET, BY USAGE,

2022–2029 (USD MILLION)   180

TABLE 217               FRANCE: LONG-READ SEQUENCING MARKET, BY END USER,

2022–2029 (USD MILLION)   181

TABLE 218               ITALY: LONG-READ SEQUENCING MARKET, BY OFFERING,

2022–2029 (USD MILLION)   182

TABLE 219               ITALY: LONG-READ SEQUENCING MARKET, BY WORKFLOW,

2022–2029 (USD MILLION)   182

TABLE 220               ITALY: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)   182

TABLE 221               ITALY: LONG-READ SEQUENCING MARKET, BY APPLICATION,

2022–2029 (USD MILLION)   183

TABLE 222               ITALY: LONG-READ SEQUENCING MARKET, BY USAGE, 2022–2029 (USD MILLION) 183

TABLE 223               ITALY: LONG-READ SEQUENCING MARKET, BY END USER,

2022–2029 (USD MILLION)   183

TABLE 224               SPAIN: LONG-READ SEQUENCING MARKET, BY OFFERING,

2022–2029 (USD MILLION)   184

TABLE 225               SPAIN: LONG-READ SEQUENCING MARKET, BY WORKFLOW,

2022–2029 (USD MILLION)   185

TABLE 226               SPAIN: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)   185

TABLE 227               SPAIN: LONG-READ SEQUENCING MARKET, BY APPLICATION,

2022–2029 (USD MILLION)   185

TABLE 228               SPAIN: LONG-READ SEQUENCING MARKET, BY USAGE, 2022–2029 (USD MILLION) 186

TABLE 229               SPAIN: LONG-READ SEQUENCING MARKET, BY END USER,

2022–2029 (USD MILLION)   186

TABLE 230               REST OF EUROPE: LONG-READ SEQUENCING MARKET, BY OFFERING,

2022–2029 (USD MILLION)   187

TABLE 231               REST OF EUROPE: LONG-READ SEQUENCING MARKET, BY WORKFLOW,

2022–2029 (USD MILLION)   187

TABLE 232               REST OF EUROPE: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)   188

TABLE 233               REST OF EUROPE: LONG-READ SEQUENCING MARKET, BY APPLICATION,

2022–2029 (USD MILLION)   188

TABLE 234               REST OF EUROPE: LONG-READ SEQUENCING MARKET, BY USAGE,

2022–2029 (USD MILLION)   188

TABLE 235               REST OF EUROPE: LONG-READ SEQUENCING MARKET, BY END USER,

2022–2029 (USD MILLION)   189

TABLE 236               ASIA PACIFIC: LONG-READ SEQUENCING MARKET, BY COUNTRY,

2022–2029 (USD MILLION)   191

TABLE 237               ASIA PACIFIC: LONG-READ SEQUENCING MARKET, BY OFFERING,

2022–2029 (USD MILLION)   191

TABLE 238               ASIA PACIFIC: LONG-READ SEQUENCING MARKET, BY WORKFLOW,

2022–2029 (USD MILLION)   191

TABLE 239               ASIA PACIFIC: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)   192

TABLE 240               ASIA PACIFIC: LONG-READ SEQUENCING MARKET, BY APPLICATION,

2022–2029 (USD MILLION)   192

TABLE 241               ASIA PACIFIC: LONG-READ SEQUENCING MARKET, BY USAGE,

2022–2029 (USD MILLION)   192

TABLE 242               ASIA PACIFIC: LONG-READ SEQUENCING MARKET, BY END USER,

2022–2029 (USD MILLION)   193

TABLE 243               CHINA: LONG-READ SEQUENCING MARKET, BY OFFERING,

2022–2029 (USD MILLION)   194

TABLE 244               CHINA: LONG-READ SEQUENCING MARKET, BY WORKFLOW,

2022–2029 (USD MILLION)   194

TABLE 245               CHINA: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)   194

TABLE 246               CHINA: LONG-READ SEQUENCING MARKET, BY APPLICATION,

2022–2029 (USD MILLION)   195

TABLE 247               CHINA: LONG-READ SEQUENCING MARKET, BY USAGE, 2022–2029 (USD MILLION) 195

TABLE 248               CHINA: LONG-READ SEQUENCING MARKET, BY END USER,

2022–2029 (USD MILLION)   195

TABLE 249               JAPAN: LONG-READ SEQUENCING MARKET, BY OFFERING,

2022–2029 (USD MILLION)   196

TABLE 250               JAPAN: LONG-READ SEQUENCING MARKET, BY WORKFLOW,

2022–2029 (USD MILLION)   196

TABLE 251               JAPAN: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)   197

TABLE 252               JAPAN: LONG-READ SEQUENCING MARKET, BY APPLICATION,

2022–2029 (USD MILLION)   197

TABLE 253               JAPAN: LONG-READ SEQUENCING MARKET, BY USAGE, 2022–2029 (USD MILLION) 197

TABLE 254               JAPAN: LONG-READ SEQUENCING MARKET, BY END USER,

2022–2029 (USD MILLION)   198

TABLE 255               INDIA: LONG-READ SEQUENCING MARKET, BY OFFERING,

2022–2029 (USD MILLION)   199

TABLE 256               INDIA: LONG-READ SEQUENCING MARKET, BY WORKFLOW,

2022–2029 (USD MILLION)   199

TABLE 257               INDIA: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)   199

TABLE 258               INDIA: LONG-READ SEQUENCING MARKET, BY APPLICATION,

2022–2029 (USD MILLION)   200

TABLE 259               INDIA: LONG-READ SEQUENCING MARKET, BY USAGE, 2022–2029 (USD MILLION) 200

TABLE 260               INDIA: LONG-READ SEQUENCING MARKET, BY END USER,

2022–2029 (USD MILLION)   200

TABLE 261               SOUTH KOREA: LONG-READ SEQUENCING MARKET, BY OFFERING,

2022–2029 (USD MILLION)   201

TABLE 262               SOUTH KOREA: LONG-READ SEQUENCING MARKET, BY WORKFLOW,

2022–2029 (USD MILLION)   202

TABLE 263               SOUTH KOREA: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)   202

TABLE 264               SOUTH KOREA: LONG-READ SEQUENCING MARKET, BY APPLICATION,

2022–2029 (USD MILLION)   202

TABLE 265               SOUTH KOREA: LONG-READ SEQUENCING MARKET, BY USAGE,

2022–2029 (USD MILLION)   203

TABLE 266               SOUTH KOREA: LONG-READ SEQUENCING MARKET, BY END USER,

2022–2029 (USD MILLION)   203

TABLE 267               REST OF ASIA PACIFIC: LONG-READ SEQUENCING MARKET, BY OFFERING,

2022–2029 (USD MILLION)   204

TABLE 268               REST OF ASIA PACIFIC: LONG-READ SEQUENCING MARKET, BY WORKFLOW,  2022–2029 (USD MILLION)   204

TABLE 269               REST OF ASIA PACIFIC: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY,  2022–2029 (USD MILLION)   205

TABLE 270               REST OF ASIA PACIFIC: LONG-READ SEQUENCING MARKET, BY APPLICATION,  2022–2029 (USD MILLION)   205

TABLE 271               REST OF ASIA PACIFIC: LONG-READ SEQUENCING MARKET, BY USAGE,

2022–2029 (USD MILLION)   205

TABLE 272               REST OF ASIA PACIFIC: LONG-READ SEQUENCING MARKET, BY END USER,

2022–2029 (USD MILLION)   206

TABLE 273               LATIN AMERICA: LONG-READ SEQUENCING MARKET, BY COUNTRY,

2022–2029 (USD MILLION)   206

TABLE 274               LATIN AMERICA: LONG-READ SEQUENCING MARKET, BY OFFERING,

2022–2029 (USD MILLION)   207

TABLE 275               LATIN AMERICA: LONG-READ SEQUENCING MARKET, BY WORKFLOW,

2022–2029 (USD MILLION)   207

TABLE 276               LATIN AMERICA: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)   207

TABLE 277               LATIN AMERICA: LONG-READ SEQUENCING MARKET, BY APPLICATION,

2022–2029 (USD MILLION)   208

TABLE 278               LATIN AMERICA: LONG-READ SEQUENCING MARKET, BY USAGE,

2022–2029 (USD MILLION)   208

TABLE 279               LATIN AMERICA: LONG-READ SEQUENCING MARKET, BY END USER,

2022–2029 (USD MILLION)   208

TABLE 280               BRAZIL: LONG-READ SEQUENCING MARKET, BY OFFERING,

2022–2029 (USD MILLION)   209

TABLE 281               BRAZIL: LONG-READ SEQUENCING MARKET, BY WORKFLOW,

2022–2029 (USD MILLION)   209

TABLE 282               BRAZIL: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)   210

TABLE 283               BRAZIL: LONG-READ SEQUENCING MARKET, BY APPLICATION,

2022–2029 (USD MILLION)   210

TABLE 284               BRAZIL: LONG-READ SEQUENCING MARKET, BY USAGE,

2022–2029 (USD MILLION)   210

TABLE 285               BRAZIL: LONG-READ SEQUENCING MARKET, BY END USER,

2022–2029 (USD MILLION)   211

TABLE 286               MEXICO: LONG-READ SEQUENCING MARKET, BY OFFERING,

2022–2029 (USD MILLION)   211

TABLE 287               MEXICO: LONG-READ SEQUENCING MARKET, BY WORKFLOW,

2022–2029 (USD MILLION)   212

TABLE 288               MEXICO: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)   212

TABLE 289               MEXICO: LONG-READ SEQUENCING MARKET, BY APPLICATION,

2022–2029 (USD MILLION) 212

TABLE 290               MEXICO: LONG-READ SEQUENCING MARKET, BY USAGE,

2022–2029 (USD MILLION)   213

TABLE 291               MEXICO: LONG-READ SEQUENCING MARKET, BY END USER,

2022–2029 (USD MILLION)   213

TABLE 292               ARGENTINA: LONG-READ SEQUENCING MARKET, BY OFFERING,

2022–2029 (USD MILLION)   214

TABLE 293               ARGENTINA: LONG-READ SEQUENCING MARKET, BY WORKFLOW,

2022–2029 (USD MILLION)   214

TABLE 294               ARGENTINA: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)   214

TABLE 295               ARGENTINA: LONG-READ SEQUENCING MARKET, BY APPLICATION,

2022–2029 (USD MILLION)   215

TABLE 296               ARGENTINA: LONG-READ SEQUENCING MARKET, BY USAGE,

2022–2029 (USD MILLION)   215

TABLE 297               ARGENTINA: LONG-READ SEQUENCING MARKET, BY END USER,

2022–2029 (USD MILLION)   215

TABLE 298               REST OF LATIN AMERICA: LONG-READ SEQUENCING MARKET, BY OFFERING,  2022–2029 (USD MILLION)   216

TABLE 299               REST OF LATIN AMERICA: LONG-READ SEQUENCING MARKET, BY WORKFLOW,  2022–2029 (USD MILLION)   216

TABLE 300               REST OF LATIN AMERICA: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY,  2022–2029 (USD MILLION)   217

TABLE 301               REST OF LATIN AMERICA: LONG-READ SEQUENCING MARKET, BY APPLICATION,  2022–2029 (USD MILLION)   217

TABLE 302               REST OF LATIN AMERICA: LONG-READ SEQUENCING MARKET, BY USAGE,

2022–2029 (USD MILLION)   217

TABLE 303               REST OF LATIN AMERICA: LONG-READ SEQUENCING MARKET, BY END USER,  2022–2029 (USD MILLION)   218

TABLE 304               MIDDLE EAST: LONG-READ SEQUENCING MARKET, BY REGION,

2022–2029 (USD MILLION)   218

TABLE 305               MIDDLE EAST: LONG-READ SEQUENCING MARKET, BY OFFERING,

2022–2029 (USD MILLION)   219

TABLE 306               MIDDLE EAST: LONG-READ SEQUENCING MARKET, BY WORKFLOW,

2022–2029 (USD MILLION)   219

TABLE 307               MIDDLE EAST: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)   219

TABLE 308               MIDDLE EAST: LONG-READ SEQUENCING MARKET, BY APPLICATION,

2022–2029 (USD MILLION) 220

TABLE 309               MIDDLE EAST: LONG-READ SEQUENCING MARKET, BY USAGE,

2022–2029 (USD MILLION)   220

TABLE 310               MIDDLE EAST: LONG-READ SEQUENCING MARKET, BY END USER,

2022–2029 (USD MILLION)   220

TABLE 311               GCC COUNTRIES: LONG-READ SEQUENCING MARKET, BY COUNTRY,

2022–2029 (USD MILLION)   221

TABLE 312               GCC COUNTRIES: LONG-READ SEQUENCING MARKET, BY OFFERING,

2022–2029 (USD MILLION)   221

TABLE 313               GCC COUNTRIES: LONG-READ SEQUENCING MARKET, BY WORKFLOW,

2022–2029 (USD MILLION)   222

TABLE 314               GCC COUNTRIES: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)   222

TABLE 315               GCC COUNTRIES: LONG-READ SEQUENCING MARKET, BY APPLICATION,

2022–2029 (USD MILLION)   222

TABLE 316               GCC COUNTRIES: LONG-READ SEQUENCING MARKET, BY USAGE,

2022–2029 (USD MILLION)   223

TABLE 317               GCC COUNTRIES: LONG-READ SEQUENCING MARKET, BY END USER,

2022–2029 (USD MILLION)   223

TABLE 318               SAUDI ARABIA: LONG-READ SEQUENCING MARKET, BY OFFERING,

2022–2029 (USD MILLION)   224

TABLE 319               SAUDI ARABIA: LONG-READ SEQUENCING MARKET, BY WORKFLOW,

2022–2029 (USD MILLION)   224

TABLE 320               SAUDI ARABIA: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION) 225

TABLE 321               SAUDI ARABIA: LONG-READ SEQUENCING MARKET, BY APPLICATION,

2022–2029 (USD MILLION)   225

TABLE 322               SAUDI ARABIA: LONG-READ SEQUENCING MARKET, BY USAGE,

2022–2029 (USD MILLION)   225

TABLE 323               SAUDI ARABIA: LONG-READ SEQUENCING MARKET, BY END USER,

2022–2029 (USD MILLION) 226

TABLE 324               UAE: LONG-READ SEQUENCING MARKET, BY OFFERING,

2022–2029 (USD MILLION)   227

TABLE 325               UAE: LONG-READ SEQUENCING MARKET, BY WORKFLOW,

2022–2029 (USD MILLION)   227

TABLE 326               UAE: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)   227

TABLE 327               UAE: LONG-READ SEQUENCING MARKET, BY APPLICATION,

2022–2029 (USD MILLION)   228

TABLE 328               UAE: LONG-READ SEQUENCING MARKET, BY USAGE, 2022–2029 (USD MILLION) 228

TABLE 329               UAE: LONG-READ SEQUENCING MARKET, BY END USER,

2022–2029 (USD MILLION)   228

TABLE 330               REST OF GCC COUNTRIES: LONG-READ SEQUENCING MARKET, BY OFFERING,  2022–2029 (USD MILLION)   229

TABLE 331               REST OF GCC COUNTRIES: LONG-READ SEQUENCING MARKET, BY WORKFLOW,  2022–2029 (USD MILLION)   230

TABLE 332               REST OF GCC COUNTRIES: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY,  2022–2029 (USD MILLION)         230

TABLE 333              REST OF GCC COUNTRIES: LONG-READ SEQUENCING MARKET, BY APPLICATION,  2022–2029 (USD MILLION)   230

TABLE 334               REST OF GCC COUNTRIES: LONG-READ SEQUENCING MARKET, BY USAGE,

2022–2029 (USD MILLION)   231

TABLE 335               REST OF GCC COUNTRIES: LONG-READ SEQUENCING MARKET, BY END USER,  2022–2029 (USD MILLION)   231

TABLE 336               REST OF MIDDLE EAST: LONG-READ SEQUENCING MARKET, BY OFFERING,

2022–2029 (USD MILLION)   232

TABLE 337               REST OF MIDDLE EAST: LONG-READ SEQUENCING MARKET, BY WORKFLOW,  2022–2029 (USD MILLION)   232

TABLE 338               REST OF MIDDLE EAST: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY,  2022–2029 (USD MILLION)   233

TABLE 339               REST OF MIDDLE EAST: LONG-READ SEQUENCING MARKET, BY APPLICATION,  2022–2029 (USD MILLION)   233

TABLE 340               REST OF MIDDLE EAST: LONG-READ SEQUENCING MARKET, BY USAGE,

2022–2029 (USD MILLION)   233

TABLE 341               REST OF MIDDLE EAST: LONG-READ SEQUENCING MARKET, BY END USER,

2022–2029 (USD MILLION)   234

TABLE 342               AFRICA: LONG-READ SEQUENCING MARKET, BY OFFERING,

2022–2029 (USD MILLION)   235

TABLE 343               AFRICA: LONG-READ SEQUENCING MARKET, BY WORKFLOW,

2022–2029 (USD MILLION)   235

TABLE 344               AFRICA: LONG-READ SEQUENCING MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)   235

TABLE 345               AFRICA: LONG-READ SEQUENCING MARKET, BY APPLICATION,

2022–2029 (USD MILLION) 236

TABLE 346               AFRICA: LONG-READ SEQUENCING MARKET, BY USAGE,

2022–2029 (USD MILLION)   236

TABLE 347               AFRICA: LONG-READ SEQUENCING MARKET, BY END USER,

2022–2029 (USD MILLION)   236

TABLE 348               OVERVIEW OF STRATEGIES ADOPTED BY KEY LONG-READ SEQUENCING COMPANIES             237

TABLE 349               LONG-READ SEQUENCING MARKET: DEGREE OF COMPETITION            242

TABLE 350               LONG-READ SEQUENCING MARKET: REGION FOOTPRINT      245

TABLE 351               LONG-READ SEQUENCING MARKET: OFFERING FOOTPRINT 246

TABLE 352               LONG-READ SEQUENCING MARKET: APPLICATION FOOTPRINT              247

TABLE 353               LONG-READ SEQUENCING MARKET: TECHNOLOGY FOOTPRINT             247

TABLE 354               LONG-READ SEQUENCING MARKET: DETAILED LIST OF KEY STARTUPS/SMES                  249

TABLE 355               LONG-READ SEQUENCING MARKET: COMPANY FOOTPRINT (STARTUPS/SMES)                  250

TABLE 356               LONG-READ SEQUENCING MARKET: DEALS, JANUARY 2021–JUNE 2024                  253

TABLE 357               LONG-READ SEQUENCING MARKET: EXPANSIONS, JANUARY 2021–JUNE 2024                  254

TABLE 358               OXFORD NANOPORE TECHNOLOGIES PLC: COMPANY OVERVIEW          255

TABLE 359               OXFORD NANOPORE TECHNOLOGIES PLC: PRODUCTS & SERVICES OFFERED                  256

TABLE 360               OXFORD NANOPORE TECHNOLOGIES PLC: DEALS, JANUARY 2021–JUNE 2024                  257

TABLE 361               PACBIO: COMPANY OVERVIEW                 259

TABLE 362               PACBIO: PRODUCTS & SERVICES OFFERED            260

TABLE 363               PACBIO: PRODUCT & SERVICE LAUNCHES, JANUARY 2021–JUNE 2024                  262

TABLE 364               PACBIO: DEALS, JANUARY 2021–JUNE 2024         262

TABLE 365               PACBIO: EXPANSIONS, JANUARY 2021–JUNE 2024                263

TABLE 366               PACBIO: OTHER DEVELOPMENTS, JANUARY 2021–JUNE 2024             263

TABLE 367               ILLUMINA, INC.: COMPANY OVERVIEW    265

TABLE 368               ILLUMINA, INC.: PRODUCTS & SERVICES OFFERED                 266

TABLE 369               ILLUMINA, INC.: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2024     267

TABLE 370               AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW            269

TABLE 371               AGILENT TECHNOLOGIES, INC.: PRODUCTS & SERVICES OFFERED       270

TABLE 372               THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW       272

TABLE 373               THERMO FISHER SCIENTIFIC INC.: PRODUCTS & SERVICES OFFERED  273

TABLE 374               10X GENOMICS, INC.: COMPANY OVERVIEW           275

TABLE 375               10X GENOMICS, INC.: PRODUCTS & SERVICES OFFERED      276

TABLE 376               10X GENOMICS, INC.: PRODUCT LAUNCHES, JANUARY 2021–JUNE 2024                  277

TABLE 377               QIAGEN: COMPANY OVERVIEW                278

TABLE 378               QIAGEN: PRODUCTS & SERVICES OFFERED            279

TABLE 379               QIAGEN: EXPANSIONS, JANUARY 2021–JUNE 2024               280

TABLE 380               BGI GROUP: COMPANY OVERVIEW          281

TABLE 381               BGI GROUP: PRODUCTS & SERVICES OFFERED     281

TABLE 382               AZENTA US, INC.: COMPANY OVERVIEW 282

TABLE 383               AZENTA US, INC.: PRODUCTS & SERVICES OFFERED              283

TABLE 384               AZENTA US, INC.: EXPANSIONS, JANUARY 2021–JUNE 2024                 284

TABLE 385               TAKARA BIO INC.: COMPANY OVERVIEW 285

TABLE 386               TAKARA BIO INC.: PRODUCTS & SERVICES OFFERED              286

TABLE 387               TAKARA BIO INC.: DEALS, JANUARY 2021–JUNE 2024           287

TABLE 388               NOVOGENE CO., LTD.: COMPANY OVERVIEW          288

TABLE 389               NOVOGENE CO., LTD.: PRODUCTS & SERVICES OFFERED      288

TABLE 390               NOVOGENE CO., LTD.: OTHER DEVELOPMENTS, JANUARY 2021–JUNE 2024                  289

TABLE 391               REVVITY, INC.: COMPANY OVERVIEW      290

TABLE 392               REVVITY INC.: PRODUCTS & SERVICES OFFERED   291

TABLE 393               DANAHER CORPORATION: COMPANY OVERVIEW   292

TABLE 394               DANAHER CORPORATION: PRODUCTS & SERVICES OFFERED                293

TABLE 395               NEW ENGLAND BIOLABS: COMPANY OVERVIEW    294

TABLE 396               NEW ENGLAND BIOLABS: PRODUCTS & SERVICES OFFERED                 294

TABLE 397               BASE CLEAR BV: COMPANY OVERVIEW  295

TABLE 398               BASE CLEAR BV: PRODUCTS & SERVICES OFFERED               295

LIST OF FIGURES

FIGURE 1 LONG-READ SEQUENCING MARKET SEGMENTATION              33

FIGURE 2 RESEARCH DESIGN 35

FIGURE 3 LONG-READ SEQUENCING MARKET: BREAKDOWN OF PRIMARY INTERVIEWS      37

FIGURE 4 LONG-READ SEQUENCING MARKET SIZE ESTIMATION: SUPPLY-SIDE

ANALYSIS, 2023      38

FIGURE 5 MARKET SIZE ESTIMATION: COMPANY REVENUE ANALYSIS-BASED

ESTIMATION, 2023 39

FIGURE 6 REVENUE SHARE ANALYSIS: ILLUSTRATIVE EXAMPLE OF AGILENT

TECHNOLOGIES, INC.               39

FIGURE 7 MARKET SIZE VALIDATION FROM PRIMARY SOURCES            40

FIGURE 8 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH    41

FIGURE 9 LONG-READ SEQUENCING MARKET: CAGR PROJECTIONS     42

FIGURE 10                DATA TRIANGULATION              44

FIGURE 11                LONG-READ SEQUENCING MARKET, BY OFFERING,  2024 VS. 2029 (USD MILLION) 46

FIGURE 12                LONG-READ SEQUENCING MARKET, BY TECHNOLOGY,

2024 VS. 2029 (USD MILLION)                47

FIGURE 13                LONG-READ SEQUENCING MARKET, BY WORKFLOW,

2024 VS. 2029 (USD MILLION)                47

FIGURE 14                LONG-READ SEQUENCING MARKET, BY APPLICATION,

2024 VS. 2029 (USD MILLION)                48

FIGURE 15                LONG-READ SEQUENCING MARKET, BY USAGE, 2024 VS. 2029 (USD MILLION)                  49

FIGURE 16                LONG-READ SEQUENCING MARKET, BY END USER,  2024 VS. 2029 (USD MILLION) 49

FIGURE 17                LONG-READ SEQUENCING MARKET: REGIONAL SNAPSHOT  50

FIGURE 18                GROWING TREND OF PERSONALIZED MEDICINES AND GENOMICS RESEARCH TO DRIVE MARKET  51

FIGURE 19                CONSUMABLES SEGMENT AND CHINA ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC LONG-READ SEQUENCING MARKET IN 2023    52

FIGURE 20                CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD         53

FIGURE 21                ACADEMIC & RESEARCH INSTITUTES SEGMENT DOMINATED MARKET IN 2023                  53

FIGURE 22                LONG-READ SEQUENCING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,

AND CHALLENGES  54

FIGURE 23                REVENUE SHIFT AND NEW REVENUE POCKETS FOR PLAYERS IN LONG-READ SEQUENCING MARKET             59

FIGURE 24                LONG-READ SEQUENCING MARKET: VALUE CHAIN ANALYSIS                 63

FIGURE 25                AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY INSTRUMENT,

2021–2023 (USD)  69

FIGURE 26                AVERAGE SELLING PRICE OF KEY PLAYERS, BY CONSUMABLE,  2021–2023 (USD)       70

FIGURE 27                AVERAGE SELLING PRICE OF KEY PLAYERS, BY SERVICE, 2023 (USD) 71

FIGURE 28                INDICATIVE PRICE TREND OF INSTRUMENTS, BY REGION, 2021–2023 (USD)                  71

FIGURE 29                PATENT ANALYSIS, 2014–2024              72

FIGURE 30                LONG-READ SEQUENCING MARKET: SUPPLY CHAIN ANALYSIS              75

FIGURE 31                LONG-READ SEQUENCING MARKET: ECOSYSTEM ANALYSIS 75

FIGURE 32                LONG-READ SEQUENCING MARKET: PORTER’S FIVE FORCES ANALYSIS                  78

FIGURE 33                INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY OFFERING 80

FIGURE 34                KEY BUYING CRITERIA, BY END USER     80

FIGURE 35                RESEARCH FUNDING BY VARIOUS INSTITUTES/CENTERS,

2020–2024 (USD MILLION)   82

FIGURE 36                LONG-READ SEQUENCING INSTRUMENTS MARKET, BY VOLUME (2022-2029)                  161

FIGURE 37                NORTH AMERICA: LONG-READ SEQUENCING MARKET SNAPSHOT        162

FIGURE 38                ASIA PACIFIC: LONG-READ SEQUENCING MARKET SNAPSHOT               190

FIGURE 39                REVENUE ANALYSIS OF KEY PLAYERS IN LONG-READ SEQUENCING MARKET, 2019–2023 (USD MILLION)   239

FIGURE 40                LONG-READ SEQUENCING MARKET SHARE ANALYSIS, BY KEY PLAYER (2023)                  240

FIGURE 41                LONG-READ SEQUENCING INSTRUMENTS MARKET SHARE ANALYSIS, BY KEY PLAYER (2023)        240

FIGURE 42                LONG-READ SEQUENCING CONSUMABLES MARKET SHARE ANALYSIS, BY KEY PLAYER (2023)        241

FIGURE 43                LONG-READ SEQUENCING SERVICES MARKET SHARE ANALYSIS, BY KEY PLAYER (2023)        241

FIGURE 44                LONG-READ SEQUENCING MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023      244

FIGURE 45                LONG-READ SEQUENCING MARKET: COMPANY FOOTPRINT  245

FIGURE 46                LONG-READ SEQUENCING MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023       249

FIGURE 47                EV/EBITDA OF KEY VENDORS 250

FIGURE 48                YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF  KEY VENDORS                 251

FIGURE 49                LONG-READ SEQUENCING MARKET: BRAND/SERVICE COMPARATIVE ANALYSIS                  252

FIGURE 50                OXFORD NANOPORE TECHNOLOGIES PLC: COMPANY SNAPSHOT (2023)                  256

FIGURE 51                PACBIO: COMPANY SNAPSHOT (2023)   260

FIGURE 52                ILLUMINA, INC.: COMPANY SNAPSHOT (2023)       266

FIGURE 53                AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2023)               270

FIGURE 54                THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023)          273

FIGURE 55                10X GENOMICS, INC.: COMPANY SNAPSHOT (2023)              276

FIGURE 56                QIAGEN: COMPANY SNAPSHOT (2023)  279

FIGURE 57                AZENTA US, INC.: COMPANY SNAPSHOT (2023)    283

FIGURE 58                TAKARA BIO INC.: COMPANY SNAPSHOT (2023)    286

FIGURE 59                REVVITY, INC.: COMPANY SNAPSHOT (2023)         291

FIGURE 60                DANAHER CORPORATION: COMPANY SNAPSHOT (2023)       293

MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。

※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

ライセンスタイプ4

ミニレポート　※定性調査にフォーカスした調査レポートです。詳細はお問合せください。

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • マルチユーザライセンス
    • 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
  • コーポレートライセンス
    • 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
  • エンタープライズサイトライセンス
    • 特別ライセンスです。適用範囲についてはお問合せください。
• 納品形態
  • Eメール
• 納期
  • 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
• 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
• ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11

MarketsandMarkets  出版レポート一覧